greeksoup/ stock research
Stock research / United States / Funds / Bruce & Co., Inc.

Bruce & Co., Inc.

CIK 1358331 · latest 13F filed 14 August 2026 · Read the filing on EDGAR

Bruce & Co., Inc. reported 41 US-listed holdings worth $369.5 million in its 13F for the quarter ended 30 June 2026, filed 14 August 2026. Its largest: AbbVie Inc. (8.2%), Allstate Corp. (7.9%) and AerCap Holdings N.V. (7.3%). Against the quarter before, it opened 0 positions, added to 4, trimmed 18 and sold out of 0.

Reported holdings$369.5M+5.7% on Q1 2026
Positions41as many as Q1 2026
The largest ten60.6%of its reported holdings
Latest 13FQ2 2026filed 14 August 2026
Where the money is
Added toHeldTrimmed
ABBV8.2%ALL7.9%AER7.3%Nextera7.0%Merck6.6%UHALB6.5%DUK5.0%VICR4.9%XEL4.0%CMS3.2%T2.9%AAPL2.9%BBNX2.8%IIIN2.8%27 more28.0%

The 14 largest of its 41 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.

Reported holdings, quarter by quarter
Q3 2024: $342.1 million in 39 positions$342MQ3 24Q4 2024: $309.9 million in 39 positions$310MQ4 24Q1 2025: $310.5 million in 41 positions$311MQ1 25Q2 2025: $307.8 million in 40 positions$308MQ2 25Q3 2025: $322.9 million in 39 positions$323MQ3 25Q4 2025: $322.5 million in 39 positions$323MQ4 25Q1 2026: $349.7 million in 41 positions$350MQ1 26Q2 2026: $369.5 million in 41 positions$369MQ2 26

What the fund reported holding at each quarter's end; hover a bar for the number of positions

What its reported holdings returned

Held through each quarter, the holdings it reported returned +25.4% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.

Its reported holdingsThe S&P 500
100110120130Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Its holdings +25.4%S&P 500 +30.2%

Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.

What it did on the quarter

Added 4Held 19Trimmed 18
Added: 4Held: 19Trimmed: 18

Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held

Added to 4

  1. Supernus Pharmaceuticals, Inc. SUPN+50,000 shares · +50%
  2. Beta Bionics Inc BBNX+115,000 shares · +21%
  3. Fate Therapeutics Inc. FATE+200,000 shares · +25%
  4. AerCap Holdings N.V. AER+1,500 shares · +1%

Trimmed 18

  1. Vicor Corp. VICR-17,000 shares · -26%
  2. U Haul Holding Company UHALB-35,000 shares · -8%
  3. Allstate Corp. ALL-3,000 shares · -2%
  4. Apple Inc. AAPL-2,000 shares · -5%
  5. Nextera Energy-6,000 shares · -2%
  6. AbbVie Inc. ABBV-1,500 shares · -1%
  7. Merck & Co Inc-2,000 shares · -1%
  8. CMS Energy Corp. CMS-3,000 shares · -2%

and 10 more in the table below

What it holds

CompanySharesValueOf its bookChange in shares
AbbVie Inc. ABBV121.0K$30.4 million8.24%-1.5K
Allstate Corp. ALL122.5K$29.1 million7.89%-3.0K
AerCap Holdings N.V. AER185.0K$27.0 million7.30%+1.5K
Nextera Energy294.3K$25.8 million6.99%-6.0K
Merck & Co Inc190.8K$24.5 million6.64%-2.0K
U Haul Holding Company UHALB417.0K$24.1 million6.51%-35.0K
Duke Energy Corp. DUK144.8K$18.3 million4.96%-1.0K
Vicor Corp. VICR48.0K$18.2 million4.93%-17.0K
Xcel Energy Inc. XEL182.5K$14.7 million3.97%-2.0K
CMS Energy Corp. CMS153.0K$11.7 million3.17%-3.0K
AT&T Inc. T518.0K$10.7 million2.90%-5.0K
Apple Inc. AAPL36.9K$10.7 million2.89%-2.0K
Beta Bionics Inc BBNX665.7K$10.4 million2.82%+115.0K
Insteel Inds Inc. IIIN343.4K$10.4 million2.81%no change
Abbott Laboratories ABT112.3K$10.2 million2.76%-1.5K
Newmont Corp. NEM100.0K$9.3 million2.53%no change
Avista Corp. AVA200.0K$8.2 million2.21%-1.5K
Archer-Daniels-Midland Co. ADM100.0K$7.6 million2.07%no change
Bunge Global SA BG70.0K$7.5 million2.02%no change
Supernus Pharmaceuticals, Inc. SUPN150.0K$7.0 million1.89%+50.0K
Pfizer Inc. PFE268.2K$6.5 million1.75%-3.7K
Darling Ingredients Inc. DAR105.0K$5.7 million1.55%-1.0K
Kodiak Sciences Inc. KOD145.0K$5.6 million1.53%no change
Chemours Co. CC250.0K$5.1 million1.39%no change
U Haul Holding Company UHAL72.6K$4.8 million1.29%-1.3K
LyondellBasell Industries N.V. LYB60.0K$3.2 million0.85%no change
Personalis Inc. PSNL233.0K$3.1 million0.84%no change
Fate Therapeutics Inc. FATE989.2K$2.7 million0.72%+200.0K
Eli Lilly & Co. LLY2.0K$2.4 million0.65%no change
RLI Corp. RLI40.0K$2.4 million0.64%-800
Apogee Enterprises, Inc. APOG50.0K$2.3 million0.62%no change
Edap TMS S A FOCL438.7K$2.3 million0.61%no change
Sirius XM Holdings Inc.55.8K$1.6 million0.45%no change
Venture Global Inc. VG100.0K$1.1 million0.30%no change
Ashland15.0K$988,3500.27%no change
Viatris Inc. VTRS57.7K$916,2120.25%-583
Mannkind Corp. MNKD195.1K$831,0110.22%no change
Bausch Health124.0K$611,3200.17%no change
908 Devices Inc. MASS68.3K$594,0880.16%no change
WEC Energy Group, Inc. WEC3.9K$460,6580.12%no change
Caribou Biosciences Inc. CRBU250.0K$440,0000.12%no change
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.
Read moreChange is shares against its 13F for the quarter before.